✦ LIBER ✦

Guidelines of care for neurofibromatosis type 1

✍ Scribed by Lawrence F. Eichenfield; Moise L. Levy; Amy S. Paller; Vincent M. Riccardi; the Guidelines/Outcomes Committee*

Book ID: 117395786
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 452 KB
Volume: 37
Category: Article
ISSN: 1097-6787
DOI: 10.1016/s0190-9622(97)70182-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DNA testing for neurofibromatosis type 1

✍ Jeffrey B. Karasik; Robert W. Marion; Ali A. Javed 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Neurofibromatosis Type 1 Revisited

✍ Williams, Virginia C. (author);Lucas, John (author);Babcock, Michael A. (author) 📂 Article 📅 2009 🏛 American Academy of Pediatrics 🌐 English ⚖ 450 KB

Neurofibromatosis Type 1 Revisited

✍ Williams, Virginia C. (author);Lucas, John (author);Babcock, Michael A. (author) 📂 Article 📅 2009 🏛 American Academy of Pediatrics 🌐 English ⚖ 450 KB

Epidemiology of neurofibromatosis type 1

✍ Friedman, J.M. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 25 KB 👁 1 views

The prevalence of neurofibromatosis type 1 (NF1) is about 1/3,000. There are no known ethnic groups in which NF1 does not occur or is unusually common. The prevalence is somewhat higher in young children than in adults, a difference that probably results at least in part from the early death of some

Deletions spanning the neurofibromatosis

Deletions spanning the neurofibromatosis type 1 gene: Implications for genotype-phenotype correlations in neurofibromatosis type 1?

✍ Marjon H. Cnossen; Mieke N. van der Est; Martijn H. Breuning; Christi J. van Asp 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 1 views

Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder characterized by abnormalities of tissues predominantly derived from the neural crest. Symptoms are highly variable and severity cannot be predicted, even within families. DNA of 84 unrelated patients with NF1, unselected for clinical

Therapeutics for Childhood Neurofibromat

Therapeutics for Childhood Neurofibromatosis Type 1 and Type 2

✍ Simone L. Ardern-Holmes; Kathryn N. North 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 180 KB